LAURA HEYTENS: Open Payments
NPI 1184174997 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 10 payments from 9 companies in 2025. Trend: 2023 $760 · 2024 $968 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $163 |
| Edwards Lifesciences Corporation | 1 | $125 |
| Boston Scientific Corporation | 1 | $40 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Biosense Webster, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| PFIZER INC. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: FREESTYLE LIBRE 3, WATCHMAN FLX, VERQUVO, CARTO 3, Ozempic, REPATHA, ELIQUIS, LEQVIO.
Industry payments across LA — which companies pay providers there.
